المؤلفون: Sturm D; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Heidelberg, Germany., Capper D; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany., Andreiuolo F; Department of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn, Bonn, Germany.; Laboratory of Neuropathology, Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil.; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil., Gessi M; Department of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn, Bonn, Germany., Kölsche C; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Reinhardt A; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany., Sievers P; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany., Wefers AK; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Ebrahimi A; Department of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn, Bonn, Germany.; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany., Suwala AK; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Neurological Surgery, Helen Diller Research Center, University of California, San Francisco, San Francisco, CA, USA., Gielen GH; Department of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn, Bonn, Germany., Sill M; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany., Schrimpf D; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany., Stichel D; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany., Hovestadt V; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Daenekas B; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Rode A; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany., Hamelmann S; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany., Previti C; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany., Jäger N; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany., Buchhalter I; Omics IT and Data Management Core Facility, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany., Blattner-Johnson M; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany., Jones BC; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Heidelberg, Germany., Warmuth-Metz M; Department of Diagnostic and Interventional Neuroradiology, University Hospital of Würzburg, Würzburg, Germany.; Neuroradiological Reference Center for the Pediatric Brain Tumor (HIT) Studies of the German Society of Pediatric Oncology and Hematology, University Hospital Würzburg, since 2021 University Hospital Augsburg, Augsburg, Germany., Bison B; Neuroradiological Reference Center for the Pediatric Brain Tumor (HIT) Studies of the German Society of Pediatric Oncology and Hematology, University Hospital Würzburg, since 2021 University Hospital Augsburg, Augsburg, Germany.; Diagnostic and Interventional Neuroradiology, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Grund K; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany., Sutter C; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany., Hirsch S; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany., Dikow N; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany., Hasselblatt M; Institute of Neuropathology, University Hospital Münster, Münster, Germany., Schüller U; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Department of Paediatric Haematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany., Koch A; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Gerber NU; Department of Oncology, University Children's Hospital Zürich, Zürich, Switzerland., White CL; Genetics and Molecular Pathology Laboratory, Hudson Institute of Medical Research, Clayton, VIC, Australia.; Department of Molecular and Translational Science, Monash University, Melbourne, VIC, Australia.; Victorian Clinical Genetics Services, Parkville, VIC, Australia., Buntine MK; Genetics and Molecular Pathology Laboratory, Hudson Institute of Medical Research, Clayton, VIC, Australia.; Department of Molecular and Translational Science, Monash University, Melbourne, VIC, Australia., Kinross K; Australian and New Zealand Children's Haematology and Oncology Group (ANZCHOG), Hudson Institute of Medical Research, Clayton, VIC, Australia., Algar EM; Genetics and Molecular Pathology Laboratory, Hudson Institute of Medical Research, Clayton, VIC, Australia.; Department of Molecular and Translational Science, Monash University, Melbourne, VIC, Australia.; Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia., Hansford JR; Women's and Children's Hospital, South Australia Health and Medical Research Institute, South Australia immunoGENomics Cancer Institute, University of Adelaide, Adelaide, SA, Australia., Gottardo NG; Department of Paediatric and Adolescent Oncology/Haematology, Perth Children's Hospital, Nedlands, WA, Australia.; Centre for Child Health Research, University of Western Australia, Nedlands, WA, Australia.; Brain Tumour Research Program, Telethon Kids Institute, Nedlands, WA, Australia., Schuhmann MU; Department of Neurosurgery, University of Tuebingen, Tuebingen, Germany., Thomale UW; Department of Neurosurgery, Charité - Universitätsmedizin Berlin, Berlin, Germany., Hernáiz Driever P; German HIT-LOGGIC Registry for low-grade glioma in children and adolescents, Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Gnekow A; Swabian Children's Cancer Center, Paediatric and Adolescent Medicine, Faculty of Medicine, University Augsburg, Augsburg, Germany., Witt O; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany., Müller HL; Department of Pediatrics and Pediatric Hematology/Oncology, University Children's Hospital, Klinikum Oldenburg AöR, Oldenburg, Germany., Calaminus G; Department of Pediatric Hematology and Oncology, University Childrens' Hospital Muenster, Muenster, Germany., Fleischhack G; Pediatric Hematology and Oncology, Pediatrics III, University Children's Hospital of Essen, Essen, Germany., Kordes U; Department of Paediatric Haematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Mynarek M; Department of Paediatric Haematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Rutkowski S; Department of Paediatric Haematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Frühwald MC; Swabian Children's Cancer Center, Paediatric and Adolescent Medicine, Faculty of Medicine, University Augsburg, Augsburg, Germany., Kramm CM; Department of Child and Adolescent Health, Division of Pediatric Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany., von Deimling A; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany., Pietsch T; Department of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn, Bonn, Germany., Sahm F; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany., Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany., Jones DTW; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany. david.jones@kitz-heidelberg.de.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany. david.jones@kitz-heidelberg.de.

المصدر: Nature medicine [Nat Med] 2023 Apr; Vol. 29 (4), pp. 917-926. Date of Electronic Publication: 2023 Mar 16.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Glioma*/diagnosis , Glioma*/genetics , Brain Neoplasms*/diagnosis , Brain Neoplasms*/genetics, Adolescent ; Humans ; Child ; Multiomics ; Neuropathology ; DNA Methylation/genetics ; Mutation

المؤلفون: Fonseca A; The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.; Department of Oncology, Children's National Hospital, Washington, DC, USA., Faure-Conter C; Department of Pediatrics, Institut d'Hemato-Oncologie Pediatrique, Lyon, France., Murray MJ; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Department of Pathology, University of Cambridge, Cambridge, UK., Fangusaro J; Aflac Cancer Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA., Bailey S; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Goldman S; Phoenix Children's Hospital, University of Arizona College of Medicine, Phoenix, Arizona, USA., Khatua S; Department of Hematology/Oncology, Mayo Clinic, Rochester, Minnesota, USA., Frappaz D; Department of Pediatrics, Institut d'Hemato-Oncologie Pediatrique, Lyon, France., Calaminus G; Department of Pediatric Hematology/Oncology, University Children's Hospital Bonn, Bonn, Germany., Dhall G; Department of Pediatric Hematology Oncology, O'Neal Comprehensive Cancer Center at University of Alabama, Birmingham, Alabama, USA., Nicholson JC; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Bouffet E; The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Bartels U; The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

المصدر: Neuro-oncology [Neuro Oncol] 2022 Nov 02; Vol. 24 (11), pp. 1950-1961.

نوع المنشور: Meta-Analysis; Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Brain Neoplasms*/pathology , Neoplasms, Germ Cell and Embryonal* , Central Nervous System Neoplasms*/pathology, Humans ; Neoplasm Recurrence, Local/pathology ; Treatment Failure ; Biomarkers, Tumor ; Central Nervous System/pathology ; Retrospective Studies

المؤلفون: Morana G; Department of Neurosciences, Neuroradiology Unit, University of Turin, Turin, Italy., Shaw D; Department of Radiology, Seattle Children's Hospital and University of Washington, Seattle, WA, USA., MacDonald SM; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA., Alapetite C; Department of Radiation Oncology and Proton Center, Institut Curie, Paris, France., Ajithkumar T; Department of Radiation Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Bhatia A; Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Brisse H; Department of Imaging, Institut Curie, Paris, France., Jaimes C; Department of Radiology, Boston Children's Hospital and Dana-Farber/Harvard Cancer Center, Boston, MA, USA., Czech T; Department of Neurosurgery, Medical University of Vienna, Vienna General Hospital, Vienna, Austria., Dhall G; Division of Pediatric Hematology and Oncology, Department of Pediatrics School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Fangusaro J; Aflac Cancer and Blood Disorders Center, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA., Faure-Conter C; Institute of Paediatric Hematology and Oncology, Lyon, France., Fouladi M; Department of Pediatric Hematology and Oncology, Nationwide Children's Hospital, Columbus, OH, USA., Hargrave D; Department of Paediatric Haematology and Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK., Harreld JH; Department of Radiology, Dartmouth-Hitchcock Medical Center, Norris Cotton Cancer Center, Lebanon, NH, USA., Mitra D; Department of Neuroradiology, Royal Victoria Infirmary, Newcastle upon Tyne, UK., Nicholson JC; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Souweidane M; Department of Neurosurgery, NewYork-Presbyterian Weill Cornell Medical Center, New York, NY, USA., Timmermann B; Department of Particle Therapy, University Hospital, Essen, Germany; West German Proton Therapy Centre, Essen, Germany; West German Cancer Center, Essen, Germany., Calaminus G; Department of Paediatric Haematology and Oncology, University Hospital Bonn, Bonn, Germany., Bartels U; Pediatric Brain Tumour Program, Hospital for Sick Children, Toronto, ON, Canada., Bison B; Department of Neuroradiology, University Hospital Augsburg, Augsburg, Germany., Murray MJ; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Department of Pathology, University of Cambridge, Cambridge, UK. Electronic address: mjm16@cam.ac.uk.

المصدر: The Lancet. Oncology [Lancet Oncol] 2022 May; Vol. 23 (5), pp. e218-e228.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Brain Neoplasms*/diagnostic imaging , Brain Neoplasms*/pathology , Brain Neoplasms*/therapy , Neoplasms, Germ Cell and Embryonal*/diagnostic imaging , Neoplasms, Germ Cell and Embryonal*/therapy, Child ; Consensus ; Diagnostic Imaging ; Humans ; Treatment Outcome

المؤلفون: Frappaz D; Institut d'Hématologie Oncologie Pédiatrique, Lyon, France., Dhall G; University of Alabama at Birmingham (UAB), Birmingham, Alabama, USA., Murray MJ; Department of Pathology, University of Cambridge, Cambridge, UK.; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Goldman S; Phoenix Children's Hospital University of Arizona, Phoenix, Arizona, USA., Faure Conter C; Institut d'Hématologie Oncologie Pédiatrique, Lyon, France., Allen J; NYU Grossman School, New York, New York, USA., Kortmann RD; University of Leipzig Medical Center, Leipzig, Germany., Haas-Kogen D; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Morana G; University of Turin, Turin, Italy., Finlay J; Nationwide Children's Hospital, Columbus, Ohio, USA., Nicholson JC; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Bartels U; The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Souweidane M; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Schönberger S; Department of Pediatric Hematology and Oncology, University Hospital Essen, Essen, Germany., Vasiljevic A; Centre de Pathologie et Neuropathologie Est, Hospices Civils de Lyon, Lyon, France., Robertson P; Mott Children's Hospital, Ann Arbor, Michigan, USA., Albanese A; Royal Marsden Hospital, London, UK., Alapetite C; Institut Curie, Paris, France., Czech T; Medical University of Vienna, Vienna, Austria., Lau CC; Connecticut Children's Medical Center, Hartford, Connecticut, USA., Wen P; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Schiff D; University of Virginia School of Medicine, Charlottesville, Virginia, USA., Shaw D; Seattle Children's Hospital and University of Washington, Seattle, Washington, USA., Calaminus G; University of Bonn, Bonn, Germany., Bouffet E; The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

المصدر: Neuro-oncology [Neuro Oncol] 2022 Apr 01; Vol. 24 (4), pp. 516-527.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Brain Neoplasms*/drug therapy , Brain Neoplasms*/therapy , Germinoma*/diagnosis , Germinoma*/pathology , Germinoma*/therapy , Neoplasms, Germ Cell and Embryonal*/diagnosis , Neoplasms, Germ Cell and Embryonal*/therapy , Testicular Neoplasms*, Adolescent ; Consensus ; Humans ; Male ; Retrospective Studies ; Young Adult

المؤلفون: Tran S; Department of Radiation Oncology, Geneva University Hospital, Geneva, Switzerland., Lim PS; Department of Radiation Oncology, University College London Hospitals, London, United Kingdom., Bojaxhiu B; Department of Radiation Oncology, Triemli Hospital, Zurich, Switzerland.; Department of Radiation Oncology, Inselspital, University Hospital Bern, Bern, Switzerland., Teske C; Department of Pediatric Hematology and Oncology, University Hospital Bonn, Bonn, Germany., Baust K; Department of Pediatric Hematology and Oncology, University Hospital Bonn, Bonn, Germany., Zepter S; Center for Proton Therapy (CPT), Paul Scherrer Institute (PSI), ETH Domain, Villigen, Switzerland., Kliebsch U; Center for Proton Therapy (CPT), Paul Scherrer Institute (PSI), ETH Domain, Villigen, Switzerland., Timmermann B; Department of Particle Therapy, West German Proton Therapy Centre Essen (WPE), West German Cancer Center (WTZ), German Cancer Consortium (DKTK), University Hospital Essen, Essen, Germany., Calaminus G; Department of Pediatric Hematology and Oncology, University Hospital Bonn, Bonn, Germany., Weber DC; Department of Radiation Oncology, Inselspital, University Hospital Bern, Bern, Switzerland.; Center for Proton Therapy (CPT), Paul Scherrer Institute (PSI), ETH Domain, Villigen, Switzerland.; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.

المصدر: Pediatric blood & cancer [Pediatr Blood Cancer] 2020 Dec; Vol. 67 (12), pp. e28465. Date of Electronic Publication: 2020 Sep 09.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Quality of Life*, Brain Neoplasms/*radiotherapy , Proton Therapy/*mortality, Adolescent ; Brain Neoplasms/pathology ; Child ; Child, Preschool ; Female ; Follow-Up Studies ; Humans ; Infant ; Male ; Prognosis ; Prospective Studies ; Radiotherapy Dosage ; Retrospective Studies ; Survival Rate

المؤلفون: Limond J; Department of Psychology, University of Exeter, UK. Electronic address: j.limond@exeter.ac.uk., Thomas S; Department of Psychology and Neuropsychology, Nottingham University Hospitals NHS Trust, UK; Children's Brain Tumour Research Centre, University of Nottingham, UK., Bull KS; Clinical and Experimental Sciences, University of Southampton, UK., Calaminus G; Pediatric Hematology and Oncology, University Childrens Hospital Bonn, Germany., Lemiere J; Pediatric Hemato-Oncology, UZLeuven, Leuven, Belgium., Traunwieser T; Swabian Children's Cancer Center, University Children's Hospital, Augsburg, Germany., van Santen HM; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, UMCU, Utrecht, the Netherlands., Weiler L; Department of Pediatrics and Adolscent Medicine, General Hospital, Medical University of Vienna, Austria., Spoudeas HA; Department of Neuroendocrinology, London Centre for Paediatric and Adolescent Endocrinology at Great Ormond Street and University College Hospitals, London, UK., Chevignard M; Rehabilitation Department, Outreach Team for Children and Adolescents with Acquired Brain Injury, Saint-Maurice Hospitals, 14 Rue du Val d'Osne, 94410 Saint-Maurice, France; Sorbonne Université, Laboratoire d'Imagerie Biomédicale, LIB, 75006 Paris, France.

المصدر: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society [Eur J Paediatr Neurol] 2020 Mar; Vol. 25, pp. 59-67. Date of Electronic Publication: 2019 Oct 25.

نوع المنشور: Guideline; Journal Article

بيانات الدورية: Publisher: Saunders Country of Publication: England NLM ID: 9715169 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2130 (Electronic) Linking ISSN: 10903798 NLM ISO Abbreviation: Eur J Paediatr Neurol Subsets: MEDLINE

مواضيع طبية MeSH: Quality of Life*, Brain Neoplasms/*therapy , Clinical Trials as Topic/*standards, Child ; Child, Preschool ; Europe ; Female ; Humans ; Infant

المؤلفون: Hayden J; Department of Paediatric Haematology and Oncology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.; Department of Paediatric Haematology and Oncology, Great North Children's Hospital, Newcastle upon Tyne, UK., Murray MJ; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK mjm16@cam.ac.uk., Bartels U; Department of Paediatric Haematology and Oncology, Paediatric Brain Tumour Program, SickKids, Toronto, Ontario, Canada., Ajithkumar T; Department of Radiation Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, UK., Muthusamy B; Department of Paediatric Neuro-Ophthalmology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Penn A; Children's Brain Tumour Research Network (CBTRN), Royal Manchester Children's Hospital, Manchester, UK.; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Calaminus G; Department of Paediatric Haematology and Oncology, University Hospital Bonn, Bonn, Germany., Nicholson J; Paediatric Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

المصدر: Archives of disease in childhood [Arch Dis Child] 2020 Mar; Vol. 105 (3), pp. 247-252. Date of Electronic Publication: 2019 Oct 08.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: BMJ Pub. Group [etc.] Country of Publication: England NLM ID: 0372434 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2044 (Electronic) Linking ISSN: 00039888 NLM ISO Abbreviation: Arch Dis Child Subsets: MEDLINE

مواضيع طبية MeSH: Cost of Illness*, Brain Neoplasms/*therapy , Neoplasms, Germ Cell and Embryonal/*therapy, Adolescent ; Brain Neoplasms/diagnosis ; Brain Neoplasms/secondary ; Child ; Child, Preschool ; Early Detection of Cancer ; Humans ; Infant ; Infant, Newborn ; Neoplasms, Germ Cell and Embryonal/diagnosis ; Neoplasms, Germ Cell and Embryonal/secondary ; Retrospective Studies ; Time-to-Treatment ; Treatment Outcome

المؤلفون: Scholtes C; Pediatric Hematology/Oncology, University Children's Hospital Bonn, Bonn, Germany., Baust K; Pediatric Hematology/Oncology, University Children's Hospital Bonn, Bonn, Germany., Weinhold L; Department of Medical Biometry, Informatics, and Epidemiology, University Hospital Bonn, Bonn, Germany., Creutzig U; Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany., Gnekow A; Pediatric Hematology/Oncology, Children's Hospital Augsburg, Germany., Hinz A; Department of Medical Psychology and Medical Sociology, University of Leipzig, Germany., Kaatsch P; German Childhood Cancer Registry, Institute for Medical Biostatistics, Epidemiology, and Informatics, University of Mainz, Mainz, Germany., Kreitz K; Institute for Biostatistics and Clinical Research, University of Münster, Münster, Germany., Langer T; Pediatric Hematology/Oncology, University Children's Hospital Lübeck, Germany., Rutkowski S; Pediatric Hematology/Oncology, University Children's Hospital Hamburg, Germany., Singer S; Division of Epidemiology and Health Services Research, Institute of Medical Biostatistics, Epidemiology, and Informatics, Mainz, Germany., Spix C; German Childhood Cancer Registry, Institute for Medical Biostatistics, Epidemiology, and Informatics, University of Mainz, Mainz, Germany., Teske C; Pediatric Hematology/Oncology, University Children's Hospital Bonn, Bonn, Germany., Schmid M; Department of Medical Biometry, Informatics, and Epidemiology, University Hospital Bonn, Bonn, Germany., Dilloo D; Pediatric Hematology/Oncology, University Children's Hospital Bonn, Bonn, Germany., Calaminus G; Pediatric Hematology/Oncology, University Children's Hospital Bonn, Bonn, Germany.

المصدر: Neuro-oncology [Neuro Oncol] 2019 Aug 05; Vol. 21 (8), pp. 1069-1081.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Brain Neoplasms* , Quality of Life*, Child ; Cohort Studies ; Health Status ; Humans ; Socioeconomic Factors ; Surveys and Questionnaires ; Survivors

المؤلفون: Thomas S; Department of Paediatric Neuropsychology, Nottingham Children's Hospital, Queen's Medical Centre, Nottingham, NG7 2UH, UK; Child Brain Tumour Research Centre, School of Medicine, University of Nottingham, Queen's Medical Centre, Nottingham, NG7 2UH, UK. Electronic address: sophie.thomas@nhs.net., Reynolds D; Department of Paediatric Neuropsychology, Nottingham Children's Hospital, Queen's Medical Centre, Nottingham, NG7 2UH, UK; Child Brain Tumour Research Centre, School of Medicine, University of Nottingham, Queen's Medical Centre, Nottingham, NG7 2UH, UK., Morrall MCHJ; Department of Paediatric Neuropsychology, Leeds General Infirmary, Leeds, LS1 3EX, UK., Limond J; Psychology, College of Life and Environmental Sciences, Washington Singer Laboratories, University of Exeter, Perry Road, EX4 4QG, UK., Chevignard M; Rehabilitation Department for Children with Acquired Neurological Injury, Saint Maurice Hospitals, 14, rue du Val d'Osne, 94410, Saint Maurice, France; Sorbonne Université, CNRS, INSERM, Laboratoire d'Imagerie Biomédicale, LIB, 75006 Paris, France., Calaminus G; University Children's Hospital Bonn, Adenauerallee 119, 53113, Bonn, Germany., Poggi G; Neuro-Oncological Rehabilitation Unit- IRCCS E. Medea, Bosisio Parini, Lecco, Italy., Bennett E; Department of Paediatric Neuropsychology, Nottingham Children's Hospital, Queen's Medical Centre, Nottingham, NG7 2UH, UK., Frappaz D; Institut d'Hématologie Oncologie pédiatrique, Lyon, France., Slade D; Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Gautier J; Institut d'Hématologie Oncologie pédiatrique, Lyon, France., McQuilton P; Department of Paediatric Neuropsychology, Nottingham Children's Hospital, Queen's Medical Centre, Nottingham, NG7 2UH, UK; Child Brain Tumour Research Centre, School of Medicine, University of Nottingham, Queen's Medical Centre, Nottingham, NG7 2UH, UK., Massimino M; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Grundy R; Child Brain Tumour Research Centre, School of Medicine, University of Nottingham, Queen's Medical Centre, Nottingham, NG7 2UH, UK.

المصدر: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society [Eur J Paediatr Neurol] 2019 Jul; Vol. 23 (4), pp. 560-570. Date of Electronic Publication: 2019 May 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Saunders Country of Publication: England NLM ID: 9715169 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2130 (Electronic) Linking ISSN: 10903798 NLM ISO Abbreviation: Eur J Paediatr Neurol Subsets: MEDLINE

مواضيع طبية MeSH: Aftercare/*methods , Brain Neoplasms/*radiotherapy , Clinical Trials as Topic/*methods , Cognition/*radiation effects , Ependymoma/*radiotherapy, Adolescent ; Cancer Survivors/psychology ; Child ; Child, Preschool ; Cranial Irradiation/adverse effects ; Europe ; Female ; Humans ; Infant ; Male ; Morbidity

المؤلفون: Calaminus G; Radiation Oncology, Institut Curie, Paris, France; Paediatric Hematology/Oncology, University Children's Hospital Bonn, Bonn, Germany; Institute d'Hémato-Oncologie Pédiatrique, Centre Leon Berard, Lyon, France; Neuro-Oncology, G.Gaslini Children's Hospital, Genoa, Italy; ESPED University Düsseldorf, Düsseldorf, Germany; Radiation Therapy and Radio-oncology, University of Leipzig, Leipzig, Germany; Paediatric Hematology/Oncology, University Children's Hospital, Muenster, Germany; Paediatric Oncology, Cambridge University Hospitals, Cambridge, UK; Paediatric Oncology, Birmingham Children's Hospital, Birmingham, UK; Institute of Neuropathology, Bonn, Germany; Department of Oncology, University of Turin, Turin, Italy; Department of Radiotherapy, Royal Marsden Hospital, Surrey, UK; Department of Neuropathology, Centre Leon Berard, Lyon, France., Frappaz D; Radiation Oncology, Institut Curie, Paris, France; Paediatric Hematology/Oncology, University Children's Hospital Bonn, Bonn, Germany; Institute d'Hémato-Oncologie Pédiatrique, Centre Leon Berard, Lyon, France; Neuro-Oncology, G.Gaslini Children's Hospital, Genoa, Italy; ESPED University Düsseldorf, Düsseldorf, Germany; Radiation Therapy and Radio-oncology, University of Leipzig, Leipzig, Germany; Paediatric Hematology/Oncology, University Children's Hospital, Muenster, Germany; Paediatric Oncology, Cambridge University Hospitals, Cambridge, UK; Paediatric Oncology, Birmingham Children's Hospital, Birmingham, UK; Institute of Neuropathology, Bonn, Germany; Department of Oncology, University of Turin, Turin, Italy; Department of Radiotherapy, Royal Marsden Hospital, Surrey, UK; Department of Neuropathology, Centre Leon Berard, Lyon, France., Kortmann RD; Radiation Oncology, Institut Curie, Paris, France; Paediatric Hematology/Oncology, University Children's Hospital Bonn, Bonn, Germany; Institute d'Hémato-Oncologie Pédiatrique, Centre Leon Berard, Lyon, France; Neuro-Oncology, G.Gaslini Children's Hospital, Genoa, Italy; ESPED University Düsseldorf, Düsseldorf, Germany; Radiation Therapy and Radio-oncology, University of Leipzig, Leipzig, Germany; Paediatric Hematology/Oncology, University Children's Hospital, Muenster, Germany; Paediatric Oncology, Cambridge University Hospitals, Cambridge, UK; Paediatric Oncology, Birmingham Children's Hospital, Birmingham, UK; Institute of Neuropathology, Bonn, Germany; Department of Oncology, University of Turin, Turin, Italy; Department of Radiotherapy, Royal Marsden Hospital, Surrey, UK; Department of Neuropathology, Centre Leon Berard, Lyon, France., Krefeld B; Radiation Oncology, Institut Curie, Paris, France; Paediatric Hematology/Oncology, University Children's Hospital Bonn, Bonn, Germany; Institute d'Hémato-Oncologie Pédiatrique, Centre Leon Berard, Lyon, France; Neuro-Oncology, G.Gaslini Children's Hospital, Genoa, Italy; ESPED University Düsseldorf, Düsseldorf, Germany; Radiation Therapy and Radio-oncology, University of Leipzig, Leipzig, Germany; Paediatric Hematology/Oncology, University Children's Hospital, Muenster, Germany; Paediatric Oncology, Cambridge University Hospitals, Cambridge, UK; Paediatric Oncology, Birmingham Children's Hospital, Birmingham, UK; Institute of Neuropathology, Bonn, Germany; Department of Oncology, University of Turin, Turin, Italy; Department of Radiotherapy, Royal Marsden Hospital, Surrey, UK; Department of Neuropathology, Centre Leon Berard, Lyon, France., Saran F; Radiation Oncology, Institut Curie, Paris, France; Paediatric Hematology/Oncology, University Children's Hospital Bonn, Bonn, Germany; Institute d'Hémato-Oncologie Pédiatrique, Centre Leon Berard, Lyon, France; Neuro-Oncology, G.Gaslini Children's Hospital, Genoa, Italy; ESPED University Düsseldorf, Düsseldorf, Germany; Radiation Therapy and Radio-oncology, University of Leipzig, Leipzig, Germany; Paediatric Hematology/Oncology, University Children's Hospital, Muenster, Germany; Paediatric Oncology, Cambridge University Hospitals, Cambridge, UK; Paediatric Oncology, Birmingham Children's Hospital, Birmingham, UK; Institute of Neuropathology, Bonn, Germany; Department of Oncology, University of Turin, Turin, Italy; Department of Radiotherapy, Royal Marsden Hospital, Surrey, UK; Department of Neuropathology, Centre Leon Berard, Lyon, France., Pietsch T; Radiation Oncology, Institut Curie, Paris, France; Paediatric Hematology/Oncology, University Children's Hospital Bonn, Bonn, Germany; Institute d'Hémato-Oncologie Pédiatrique, Centre Leon Berard, Lyon, France; Neuro-Oncology, G.Gaslini Children's Hospital, Genoa, Italy; ESPED University Düsseldorf, Düsseldorf, Germany; Radiation Therapy and Radio-oncology, University of Leipzig, Leipzig, Germany; Paediatric Hematology/Oncology, University Children's Hospital, Muenster, Germany; Paediatric Oncology, Cambridge University Hospitals, Cambridge, UK; Paediatric Oncology, Birmingham Children's Hospital, Birmingham, UK; Institute of Neuropathology, Bonn, Germany; Department of Oncology, University of Turin, Turin, Italy; Department of Radiotherapy, Royal Marsden Hospital, Surrey, UK; Department of Neuropathology, Centre Leon Berard, Lyon, France., Vasiljevic A; Radiation Oncology, Institut Curie, Paris, France; Paediatric Hematology/Oncology, University Children's Hospital Bonn, Bonn, Germany; Institute d'Hémato-Oncologie Pédiatrique, Centre Leon Berard, Lyon, France; Neuro-Oncology, G.Gaslini Children's Hospital, Genoa, Italy; ESPED University Düsseldorf, Düsseldorf, Germany; Radiation Therapy and Radio-oncology, University of Leipzig, Leipzig, Germany; Paediatric Hematology/Oncology, University Children's Hospital, Muenster, Germany; Paediatric Oncology, Cambridge University Hospitals, Cambridge, UK; Paediatric Oncology, Birmingham Children's Hospital, Birmingham, UK; Institute of Neuropathology, Bonn, Germany; Department of Oncology, University of Turin, Turin, Italy; Department of Radiotherapy, Royal Marsden Hospital, Surrey, UK; Department of Neuropathology, Centre Leon Berard, Lyon, France., Garre ML; Radiation Oncology, Institut Curie, Paris, France; Paediatric Hematology/Oncology, University Children's Hospital Bonn, Bonn, Germany; Institute d'Hémato-Oncologie Pédiatrique, Centre Leon Berard, Lyon, France; Neuro-Oncology, G.Gaslini Children's Hospital, Genoa, Italy; ESPED University Düsseldorf, Düsseldorf, Germany; Radiation Therapy and Radio-oncology, University of Leipzig, Leipzig, Germany; Paediatric Hematology/Oncology, University Children's Hospital, Muenster, Germany; Paediatric Oncology, Cambridge University Hospitals, Cambridge, UK; Paediatric Oncology, Birmingham Children's Hospital, Birmingham, UK; Institute of Neuropathology, Bonn, Germany; Department of Oncology, University of Turin, Turin, Italy; Department of Radiotherapy, Royal Marsden Hospital, Surrey, UK; Department of Neuropathology, Centre Leon Berard, Lyon, France., Ricardi U; Radiation Oncology, Institut Curie, Paris, France; Paediatric Hematology/Oncology, University Children's Hospital Bonn, Bonn, Germany; Institute d'Hémato-Oncologie Pédiatrique, Centre Leon Berard, Lyon, France; Neuro-Oncology, G.Gaslini Children's Hospital, Genoa, Italy; ESPED University Düsseldorf, Düsseldorf, Germany; Radiation Therapy and Radio-oncology, University of Leipzig, Leipzig, Germany; Paediatric Hematology/Oncology, University Children's Hospital, Muenster, Germany; Paediatric Oncology, Cambridge University Hospitals, Cambridge, UK; Paediatric Oncology, Birmingham Children's Hospital, Birmingham, UK; Institute of Neuropathology, Bonn, Germany; Department of Oncology, University of Turin, Turin, Italy; Department of Radiotherapy, Royal Marsden Hospital, Surrey, UK; Department of Neuropathology, Centre Leon Berard, Lyon, France., Mann JR; Radiation Oncology, Institut Curie, Paris, France; Paediatric Hematology/Oncology, University Children's Hospital Bonn, Bonn, Germany; Institute d'Hémato-Oncologie Pédiatrique, Centre Leon Berard, Lyon, France; Neuro-Oncology, G.Gaslini Children's Hospital, Genoa, Italy; ESPED University Düsseldorf, Düsseldorf, Germany; Radiation Therapy and Radio-oncology, University of Leipzig, Leipzig, Germany; Paediatric Hematology/Oncology, University Children's Hospital, Muenster, Germany; Paediatric Oncology, Cambridge University Hospitals, Cambridge, UK; Paediatric Oncology, Birmingham Children's Hospital, Birmingham, UK; Institute of Neuropathology, Bonn, Germany; Department of Oncology, University of Turin, Turin, Italy; Department of Radiotherapy, Royal Marsden Hospital, Surrey, UK; Department of Neuropathology, Centre Leon Berard, Lyon, France., Göbel U; Radiation Oncology, Institut Curie, Paris, France; Paediatric Hematology/Oncology, University Children's Hospital Bonn, Bonn, Germany; Institute d'Hémato-Oncologie Pédiatrique, Centre Leon Berard, Lyon, France; Neuro-Oncology, G.Gaslini Children's Hospital, Genoa, Italy; ESPED University Düsseldorf, Düsseldorf, Germany; Radiation Therapy and Radio-oncology, University of Leipzig, Leipzig, Germany; Paediatric Hematology/Oncology, University Children's Hospital, Muenster, Germany; Paediatric Oncology, Cambridge University Hospitals, Cambridge, UK; Paediatric Oncology, Birmingham Children's Hospital, Birmingham, UK; Institute of Neuropathology, Bonn, Germany; Department of Oncology, University of Turin, Turin, Italy; Department of Radiotherapy, Royal Marsden Hospital, Surrey, UK; Department of Neuropathology, Centre Leon Berard, Lyon, France., Alapetite C; Radiation Oncology, Institut Curie, Paris, France; Paediatric Hematology/Oncology, University Children's Hospital Bonn, Bonn, Germany; Institute d'Hémato-Oncologie Pédiatrique, Centre Leon Berard, Lyon, France; Neuro-Oncology, G.Gaslini Children's Hospital, Genoa, Italy; ESPED University Düsseldorf, Düsseldorf, Germany; Radiation Therapy and Radio-oncology, University of Leipzig, Leipzig, Germany; Paediatric Hematology/Oncology, University Children's Hospital, Muenster, Germany; Paediatric Oncology, Cambridge University Hospitals, Cambridge, UK; Paediatric Oncology, Birmingham Children's Hospital, Birmingham, UK; Institute of Neuropathology, Bonn, Germany; Department of Oncology, University of Turin, Turin, Italy; Department of Radiotherapy, Royal Marsden Hospital, Surrey, UK; Department of Neuropathology, Centre Leon Berard, Lyon, France., Murray MJ; Radiation Oncology, Institut Curie, Paris, France; Paediatric Hematology/Oncology, University Children's Hospital Bonn, Bonn, Germany; Institute d'Hémato-Oncologie Pédiatrique, Centre Leon Berard, Lyon, France; Neuro-Oncology, G.Gaslini Children's Hospital, Genoa, Italy; ESPED University Düsseldorf, Düsseldorf, Germany; Radiation Therapy and Radio-oncology, University of Leipzig, Leipzig, Germany; Paediatric Hematology/Oncology, University Children's Hospital, Muenster, Germany; Paediatric Oncology, Cambridge University Hospitals, Cambridge, UK; Paediatric Oncology, Birmingham Children's Hospital, Birmingham, UK; Institute of Neuropathology, Bonn, Germany; Department of Oncology, University of Turin, Turin, Italy; Department of Radiotherapy, Royal Marsden Hospital, Surrey, UK; Department of Neuropathology, Centre Leon Berard, Lyon, France., Nicholson JC; Radiation Oncology, Institut Curie, Paris, France; Paediatric Hematology/Oncology, University Children's Hospital Bonn, Bonn, Germany; Institute d'Hémato-Oncologie Pédiatrique, Centre Leon Berard, Lyon, France; Neuro-Oncology, G.Gaslini Children's Hospital, Genoa, Italy; ESPED University Düsseldorf, Düsseldorf, Germany; Radiation Therapy and Radio-oncology, University of Leipzig, Leipzig, Germany; Paediatric Hematology/Oncology, University Children's Hospital, Muenster, Germany; Paediatric Oncology, Cambridge University Hospitals, Cambridge, UK; Paediatric Oncology, Birmingham Children's Hospital, Birmingham, UK; Institute of Neuropathology, Bonn, Germany; Department of Oncology, University of Turin, Turin, Italy; Department of Radiotherapy, Royal Marsden Hospital, Surrey, UK; Department of Neuropathology, Centre Leon Berard, Lyon, France.

المصدر: Neuro-oncology [Neuro Oncol] 2017 Nov 29; Vol. 19 (12), pp. 1661-1672.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Brain Neoplasms/*mortality , Chemoradiotherapy/*mortality , Cranial Irradiation/*mortality , Neoplasm Recurrence, Local/*mortality , Neoplasms, Germ Cell and Embryonal/*mortality , Testicular Neoplasms/*mortality, Adolescent ; Adult ; Biomarkers, Tumor/metabolism ; Brain Neoplasms/secondary ; Brain Neoplasms/therapy ; Child ; Child, Preschool ; Cisplatin/administration & dosage ; Etoposide/administration & dosage ; Female ; Follow-Up Studies ; Humans ; Ifosfamide/administration & dosage ; International Agencies ; Lymphatic Metastasis ; Male ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/therapy ; Neoplasms, Germ Cell and Embryonal/pathology ; Neoplasms, Germ Cell and Embryonal/therapy ; Prognosis ; Prospective Studies ; Survival Rate ; Testicular Neoplasms/pathology ; Testicular Neoplasms/therapy ; Young Adult

SCR Disease Name: Nonseminomatous germ cell tumor